KevinWHarrisMD

PubMed

• 7 citations
  Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans.
  Madison R. Chandler, Kimberly S. Keene, Johanna Tuomela, Andres Forero-Torres, Renee A. Desmond, Katri S. Vuopala, Kevin W. Harris, Nancy D. Merner, Katri S. Selander> ;Plos One. 2017 Sep 8
• 11 citations
  Toll-like receptor 9 expression is associated with breast cancer sensitivity to the growth inhibitory effects of bisphosphonates in vitro and in vivo.
  Jouko Sandholm, Jaakko Lehtimäki, Tamiko Ishizu, Sadanandan E. Velu, Jeremy Clark, Pirkko Härkönen, Arja Jukkola-Vuorinen, Aleksi Schrey, Kevin W. Harris, Johanna Tuom...> ;Oncotarget. 2016 Nov 24
• 14 citations
  Telomeric G-quadruplex-forming DNA fragments induce TLR9-mediated and LL-37-regulated invasion in breast cancer cells in vitro
  Johanna Tuomela, Jouko Sandholm, Mika Kaakinen, Katherine L. Hayden, Kirsi-Maria Haapasaari, Arja Jukkola-Vuorinen, Joonas H. Kauppila, Petri Lehenkari, Kevin W. Harri...> ;Breast Cancer Research and Treatment. 2016 Jan 18
• 20 citations
  Hypoxia regulates Toll‑like receptor‑9 expression and invasive function in human brain cancer cells in vitro
  Jouko Sandholm, Johanna Tuomela, Joonas H. Kauppila, Kevin W. Harris, David E. Graves, Katri S. Selander> ;Oncology Letters. 2014 Jul 1
• 15 citations
  Chloroquine has tumor‑inhibitory and tumor‑promoting effects in triple‑negative breast cancer
  Johanna Tuomela, Jouko Sandholm, Joonas H. Kauppila, Petri Lehenkari, Kevin W. Harris, Katri S. Selander> ;Oncology Letters. 2013 Dec 1
• 28 citations
  DNA from dead cancer cells induces TLR9-mediated invasion and inflammation in living cancer cells
  Johanna Tuomela, Jouko Sandholm, Mika Kaakinen, Ankita Patel, Joonas H. Kauppila, Joanna M. Ilvesaro, Dongquan Chen, Kevin W. Harris, David E. Graves, Katri S. Selander> ;Breast Cancer Research and Treatment. 2013 Nov 10
• Theoretical framework for stimulation in nursing: answering Schiavenato's call.
  Harris, K.,Eccles, D. W.,Ward, P.,Whyte, J.> ;J Nurs Educ. 2013 Jan
• 45 citations
  Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer
  Johanna Tuomela, Jouko Sandholm, Peeter Karihtala, Joanna M. Ilvesaro, Katri S. Vuopala, Joonas H. Kauppila, Saila Kauppila, Dongquan Chen, Christine S. Pressey, Pirkk...> ;Breast Cancer Research and Treatment. 2012 Jul 31
• Artifactual severe thrombocytopenia in a pregnant patient.
  Frölich, M. A., Tita, A., Harris, K.> ;Arch Gynecol Obstet. 2012 Nov
• 33 citations
  Distinct classes of c-Kit–activating mutations differ in their ability to promote RUNX1-ETO–associated acute myeloid leukemia
  Heidi J. Nick, Hyung-Gyoon Kim, Chia-Wei Chang, Kevin W. Harris, Vishnu Reddy, Christopher A. Klug> ;Blood. 2012 Feb 9
• 26 citations
  Estrogen receptor-α and sex steroid hormones regulate Toll-like receptor-9 expression and invasive function in human breast cancer cells
  Jouko Sandholm, Joonas H. Kauppila, Christine S. Pressey, Johanna Tuomela, Arja Jukkola-Vuorinen, Markku H. Vaarala, Martin R. Johnson, Kevin W. Harris, Katri S. Selander> ;Breast Cancer Research and Treatment. 2012 Apr 1
• 52 citations
  Expression of macrophage inhibitory cytokine-1 in prostate cancer bone metastases induces osteoclast activation and weight loss.
  Savita Wakchoure, Telisha M. Swain, Teuvo Hentunen, Asne R. Bauskin, David Brown, Samuel N. Breit, Katri S. Vuopala, Kevin W. Harris, Katri S. Selander> ;The Prostate. 2009 May 1
• 60 citations
  Toll-Like Receptor 9 Mediates CpG Oligonucleotide–Induced Cellular Invasion
  Joanna M. Ilvesaro, Melinda A. Merrell, Li Li, Savita Wakchoure, David E. Graves, Sonja C. Brooks, Eeva Rahko, Arja Jukkola-Vuorinen, Katri S. Vuopala, Kevin W. Harris...> ;Molecular Cancer Research. 2008 Oct 1
• 131 citations
  Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro.
  Joanna M. Ilvesaro, Melinda A. Merrell, Telisha M. Swain, Jennifer D. Davidson, Majd Zayzafoon, Kevin W. Harris, Katri S. Selander> ;The Prostate. 2007 May 15
• 45 citations
  An Essential Role for gp130 in Neointima Formation Following Arterial Injury
  Dong Wang, Zhimin Liu, Quanyi Li, Manjula Karpurapu, Venkatesh Kundumani-Sridharan, Huiqing Cao, Nagadhara Dronadula, Farhan Rizvi, Arun K. Bajpai, Chunxiang Zhang, Ge...> ;Circulation Research. 2007 Mar 30
• 182 citations
  Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity
  Melinda A. Merrell, Joanna M. Ilvesaro, Niko Lehtonen, Timo Sorsa, Bradley Gehrs, Eben L. Rosenthal, Dongquan Chen, Brit Shackley, Kevin W. Harris, Katri S. Selander> ;Molecular Cancer Research. 2006 Jul 1
• 40 citations
  Bisphosphonates Inhibit the Growth of Mesothelioma Cells In vitro and In vivo
  Savita Wakchoure, Melinda A. Merrell, Wayne Aldrich, Telisha Millender-Swain, Kevin W. Harris, Pierre L. Triozzi, Katri S. Selander> ;Clinical Cancer Research. 2006 May 1
• 73 citations
  Inhibition of gp130 Signaling in Breast Cancer Blocks Constitutive Activation of Stat3 and Inhibits in Vivo Malignancy
  Katri S. Selander, Li Li, Latania Watson, Melinda A. Merrell, Heike Dahmen, Peter C. Heinrich, Gerhard Müller-Newen, Kevin W. Harris> ;Cancer Research. 2004 Oct 1
• 4 citations
  Purification and characterization of the yeast-expressed erythropoietin mutant Epo (R103A), a specific inhibitor of human primary hematopoietic cell erythropoiesis
  Suzanne C. Burns, Murat O. Arcasoy, Li Li, Elizabeth M. Kurian, Katri S. Selander, Peter D. Emanuel, Kevin W. Harris> ;Blood. 2002 Jun 15
• Cultured bovine aortic endothelial cells promote activated protein C-protein S-mediated inactivation of factor Va.
  Stern DM, Nawroth PP, Harris K, Esmon CT> ;J. Biol. Chem.. 1986-01-15
• Protein S is required for bovine platelets to support activated protein C binding and activity.
  Harris KW, Esmon CT> ;J. Biol. Chem.. 1985-02-25
• Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation.
  Esmon CT, Esmon NL, Harris KW> ;J. Biol. Chem.. 1982-07-25
• Dynamic parameters of membrane lipids in normal and leukemic human lymphocytes isolated from peripheral blood and bone marrow.
  Yanovich S, Harris K, Sallan SE, Schlossman SF, Inbar M> ;Cancer Res.. 1978-12-01
• Characterization of a unique cell line (LAZ 221) from human acute lymphocytic ("null" cell) leukemia.
  Lazarus H, Barell EF, Krishan A, Livingston DM, Harris K, Schlossman SF, Chess L> ;Cancer Res.. 1978-05-01
• Localization of an essential ligand binding determinant of the human erythropoietin receptor to a domain N-terminal to the WSXWS motif: implications for soluble recept...
  Schimmenti, L. A., Blechert, G., Harris, K. W., Winkelmann, J. C.> ;Exp Hematol. 1995 Dec
• Join now to see all